Common Stock SEC Reporting - Current
Contact Info
  • 4203 SW 34 th Street
  • Orlando, FL 32811

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0000075439
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 1999
Employees 77 a/o Sep 01, 2016
Company Officers/Contacts
David E. Patterson CEO, CFO, Treasurer, Secretary
Michaela Ott COO
Company Directors
Michael Ott Chairman
John Abeles
Eric M. Goehausen
W. Austin Lewis IV
Robert McCullough, Jr.
Augusto Ocana
Service Providers
Accounting/Auditing Firm
180 S. Orange #1150
Suite 1150
Orlando, FL, 32801
United States
Securities Counsel
O'Neal Law Firm
17100 E. Shea Blvd.
Suite 400-D
Fountain Hills, AZ, 85268
United States
Investor Relations Firm

Not Available
Company History
  • Formerly=CytoCore, Inc. until 12-2014
  • Formerly=Molecular Diagnostics, Inc. until 8-06
  • Formerly=Ampersand Medical Corp. until 9-01
  • Note=5-99 State of incorporation California changed to Delaware
  • Formerly=Bell National Corp. until 5-99
  • Formerly=Pacific Coast Holdings, Inc. to 1-83
  • Note=8-85 Company filed petition under Chapter XI of the Federal Bankruptcy Act.
MDIT Security Details
Share Structure
Market Value1 $10,637,497 a/o May 24, 2017
Authorized Shares 35,000,000 a/o Sep 13, 2016
Outstanding Shares 25,881,987 a/o May 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders of Record 427 a/o Apr 14, 2017
Short Selling Data
Short Interest 7 (-12.5%)
Apr 28, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security